Literature DB >> 16529395

Degradative action of reactive oxygen species on hyaluronan.

L Soltés1, R Mendichi, G Kogan, J Schiller, M Stankovska, J Arnhold.   

Abstract

Many human diseases are associated with harmful action of reactive oxygen species (ROS). These species are involved in the degradation of essential tissue or related components. One of such components is synovial fluid that contains a high-molecular-weight polymer--hyaluronan (HA). Uninhibited and/or inhibited hyaluronan degradation by the action of various ROS has been studied in many in vitro models. In these studies, the change of the molecular weight of HA or a related parameter, such as HA solution viscosity, has been used as a marker of inflicted damage. The aim of the presented review is to briefly summarize the available data. Their correct interpretation could contribute to the implementation of modern methods of evaluation of the antioxidative capacity of natural and synthetic substances and prospective drugs--potential inflammatory disease modifying agents. Another focus of this review is to evaluate briefly the impact of different available analytical techniques currently used to investigate the structure of native high-molecular-weight hyaluronan and/or of its fragments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529395     DOI: 10.1021/bm050867v

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  75 in total

Review 1.  Consequences of metabolic and oxidative modifications of cartilage tissue.

Authors:  John A Hardin; Neil Cobelli; Laura Santambrogio
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

Review 2.  Biology and biotechnology of hyaluronan.

Authors:  Manuela Viola; Davide Vigetti; Evgenia Karousou; Maria Luisa D'Angelo; Ilaria Caon; Paola Moretto; Giancarlo De Luca; Alberto Passi
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

Review 3.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment.

Authors:  A Fakhari; C Berkland
Journal:  Acta Biomater       Date:  2013-03-15       Impact factor: 8.947

Review 4.  Therapeutic strategies for enhancing angiogenesis in wound healing.

Authors:  Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker
Journal:  Adv Drug Deliv Rev       Date:  2018-09-26       Impact factor: 15.470

Review 5.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

Review 6.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 7.  Dysregulation of redox pathways in liver fibrosis.

Authors:  Natalie J Torok
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

Review 8.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

9.  Synthesis, characterization and chondroprotective properties of a hyaluronan thioethyl ether derivative.

Authors:  Monica A Serban; Guanghui Yang; Glenn D Prestwich
Journal:  Biomaterials       Date:  2007-12-26       Impact factor: 12.479

10.  A prospective, randomised, controlled, double-blind phase I-II clinical trial on the safety of A-Part Gel as adhesion prophylaxis after major abdominal surgery versus non-treated group.

Authors:  Reinhold Lang; Petra Baumann; Karl-Walter Jauch; Claudia Schmoor; Christine Weis; Erich Odermatt; Hanns-Peter Knaebel
Journal:  BMC Surg       Date:  2010-07-06       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.